CULTURES MICROORGANISMS MEDICAL
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| CORREGENE | Corregene Biotechnology Co., Ltd | Rm.317-2, 3rd Fl., Bldg.1, No.1 Nengyuan East Road,Shahe Town, Changping District Beijing 102200 China | Cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes; veterinary preparations; stem cells for veterinary purposes; preparations for destroying noxious animals;CORRE GENE;Quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; clinical trials; genomic structure and function analysis; genetic testing for scientific research; testing of drugs; |
| CORREGENE | Corregene Biotechnology Co., Ltd. | Rm. 132, Bldg, 1, Area 1, Yard 8 Changping, Beijing 102200 China | Cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological tissue cultures for veterinary purposes; stem cells for veterinary purposes;CORRE GENE; CORE GENE;Color is not claimed as a feature of the mark.; |
| ECOACTIVE | Intralytix, Inc. | Intralytix 8681 Robert Fulton Drive Columbia MD 21046 | Cultures of microorganisms for medical or veterinary use;ECO ACTIVE; |
| ELABSCIENCE | Wuhan Elabscience Biotechnology Co., Ltd | Unit 1 Room 808, Wuhan 430000 China | Cultures of microorganisms for medical and veterinary use; vaccines; culture fluid for cultivating microorganism for medical and veterinary use;Color is not claimed as a feature of the mark.; |
| EXOLIN | DEFYMED | 9 rue Albert Calmette F-67200 STRASBOURG France | Cultures of microorganisms for medical or veterinary use; biological tissue cultures for medical or veterinary use; enzymes for medical or veterinary use; vascular grafts of living tissues; hormones for medical use; surgical implants composed of living tissue; medicines for intestinal disorders in humans; biological preparations for medical or veterinary use in treating metabolic disorders; chemical-pharmaceutical preparations for the treatment of diabetes; chemical preparations for medical or veterinary use for the treatment of diabetes; chemical preparations for pharmaceutical use in the treatment of diabetes; preparations of microorganisms for medical and veterinary use in the treatment of diabetes; diagnostic preparations for medical or veterinary use;Surgical and medical apparatus and instruments for use in implanting insulin injectors; catheters; implantable devices for the subcutaneous release of medicated substances sold empty; surgical implants comprised of artificial materials; vacuum pumps for medical use; injector devices for medical use in delivering pharmaceuticals;Conducting clinical trials for others in the fields of medical devices and pharmaceuticals; research and development of new products for others; research and development in the field of bioartificial medical devices; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; biological research services; bacteriological research services; chemical research; scientific research; technical research in the field of pharmaceutical studies; services provided by consultants relating to scientific research and development in the field of therapeutics; scientific laboratory services; |
|
|
|||
| HAPPY FLORA | McPherson's Limited | 105 Vanessa Street Kingsgrove, NSW 2208 Australia | Cultures of microorganisms for medical and veterinary use; dietary supplements; dietetic beverages adapted for medical purposes; dietetic confectionery adapted for medical purposes; dietetic drinks adapted for medical purposes; dietetic food supplements adapted for medical purposes; dietetic foods adapted for infants; dietetic foods adapted for invalids; dietetic foods adapted for medical purposes; dietetic foods for medicinal purposes; dietetic foods for use in clinical nutrition; dietetic foodstuffs for medical purposes; dietetic infusions for medical use; dietetic preparations adapted for medical use; dietetic substances adapted for medical use; dietetic substances for babies; dietetic substances for infants; dietetic substances for invalids (medical foods); dietetic substances for medical use; dietetic substances for medical use in weight control; dietetic substances for medicinal purposes; dietetic substances for veterinary use; digestants; digestive enzymes; food supplements (dietary supplements); nutriments; nutritional drinks being dietary food supplements; plant extracts (dietary supplements); protein supplements for humans; laxatives; dietary nutritional supplements; nutritional supplements for animals; nutritional supplements for humans; digestives for pharmaceutical purposes; probiotic preparations for medical use to help maintian the digestive system; probiotic supplements; |
| HOWARU B420 | DUPONT NUTRITION BIOSCIENCES APS | Langebrogade 1 Copenhagen DK-1411 Denmark | CULTURES OF MICROORGANISMS FOR MEDICAL OR VETERINARY USE; DIETETIC FOODS AND BEVERAGES ADAPTED FOR MEDICAL USE; FOOD FOR BABIES, NAMELY, INFANT FORMULA;HOW ARE YOU BEFORE FOUR HUNDRED TWENTY; HOW ARE YOU BEFORE FOUR TWENTY; HOW ARE YOU B FOUR TWO ZERO;INGREDIENTS FOR INDUSTRIAL MANUFACTURE OF FOODSTUFFS AND BEVERAGES FOR BOTH HUMAN AND ANIMAL COMSUMPTION, namely, CULTURES OF MICROORGANISMS, NOT FOR MEDICAL OR VETERINARY PURPOSES; |
| HOWARU LP-202195 | DUPONT NUTRITION BIOSCIENCES APS | Langebrogade 1 Copenhagen DK-1411 Denmark | CULTURES OF MICROORGANISMS FOR MEDICAL OR VETERINARY USE; DIETETIC FOODS AND BEVERAGES ADAPTED FOR MEDICAL USE; FOOD FOR BABIES, NAMELY, INFANT FORMULA;HOWARU LP-TWO ZERO TWO ONE NINE FIVE;INGREDIENTS FOR INDUSTRIAL MANUFACTURE OF FOODSTUFFS AND BEVERAGES FOR BOTH HUMAN AND ANIMAL COMSUMPTION, namely, CULTURES OF MICROORGANISMS, NOT FOR MEDICAL OR VETERINARY PURPOSES; |
| JETSON | JETSON HEALTH | 401 N. MICHIGAN AVE., SUITE 3300 CHICAGO IL 60611 | Cultures of microorganisms for medical or veterinary use; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements; Dietary and nutritional supplements; Herbal supplements; Herbal supplements for general health and well-being and/or to re-equilibrate the intestinal bacterial flora; Nutritional supplements; Probiotic preparations for medical use; Probiotic supplements; Vitamin and mineral supplements; Vitamin drops; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations; Dietary and nutritional supplements containing microorganism cultures, having probiotic activity for the treatment of diseases and inflammation of the intestinal tract or lower gastrointestinal tract; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Liquid herbal supplements; Liquid vitamin supplements; Medicated oils containing vitamins, minerals; Natural herbal supplements; Nutraceuticals for use as a dietary supplement for the treatment of intestinal inflammation; Nutritional supplements, namely, probiotic compositions; |
| JETTIE | Jetson Health | 401 N. Michigan Ave., Suite 3300 Chicago IL 60611 | Cultures of microorganisms for medical or veterinary use; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements; Dietary supplements for children and infants; Dietary and nutritional supplements; Dietary and nutritional supplements containing microorganism cultures, having probiotic activity for the treatment of diseases and inflammation of the intestinal tract or lower gastrointestinal tract; Dietary and nutritional supplements for children and infants; Food supplements for children and infants; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Herbal supplements; Herbal supplements for general health and well-being and/or to re-equilibrate the intestinal bacterial flora; Herbal supplements for children and infants; Liquid herbal supplements; Liquid vitamin supplements; Medicated baby oils; Medicated oils containing vitamins, minerals; Natural herbal supplements; Nutraceuticals for use as a dietary supplement for the treatment of intestinal inflammation; Nutraceuticals for the treatment of children and infants; Nutritional supplements; Nutritional supplements for children and infants; Nutritional supplements, namely, probiotic compositions; Probiotic preparations for medical use; Probiotic supplements; Vitamin drops; Vitamin supplements; Vitamin tablets; Vitamin and mineral supplements; Vitamins; Vitamins and vitamin preparations; |
| LP-33 | CHR. HANSEN A/S | Bøge Allé 10-12 Hørsholm 2970 Denmark | Cultures of microorganisms for medical and veterinary use; bacteriological preparations for medical and veterinary use; cultures of microorganisms for use in dietary supplements, food supplements, vitamin and mineral preparations; pharmaceutical preparations for the promotion of immune health and for the reduction of the symptoms of allergies through airborne allergens including pollen and dust; cultures of microorganisms for use as dietary supplement; food supplements; |
| LYOVO | EUROVO SRL | Via Mensa 3 Lugo Frazione S.Maria in Fabriago (Ravenna) Italy | Cultures of microorganisms for medical or veterinary use; antibacterial pharmaceuticals; enzymes for veterinary purposes; enzyme dietary supplements;Enzymes for the food industry; enzymes for use in the processing of food by-products; enzymes for use in protein hydrolysis; enzymes for use in the manufacture of pet food; enzymes for use in the manufacture of animal food; enzymes for use in the manufacture of nutraceuticals; enzymes to assist in digestion for use in the manufacture of animal feeds; |
| LYPRO | E.P.S. S.P.A. EGG POWDER SPECIALISTS OPPURE IN FORMA ABBREVIATA E.P.S. S.P.A. | Via Mensa, 3 Frazione: Santa Maria in Fabriago Lugo Italy | Cultures of microorganisms for medical or veterinary use; antibacterial pharmaceuticals; enzymes for veterinary purposes; enzyme dietary supplements; |
| SAFETY BY NATURE | Intralytix, Inc. | Intralytix 8681 Robert Fulton Drive Columbia MD 21046 | Cultures of microorganisms for medical or veterinary use; |
| SAN 135BC | SANZYME BIOLOGICS PRIVATE LIMITED | 8-2-120/13/5 PLOT 13 SAGAR SOC., RD. 2 BanjaraHills,Hyderabad 5000034 India | Cultures of microorganisms for medical or veterinary use; preparations of microorganisms for medical or veterinary use for the treatment of DIARRHEA, DYSBIOSIS, LOOSE DROPPINGS, WET LITTER and AMMONIA GENERATION, MASTITIS, NECROTIC ENTERITIS, SALMONELLOSIS and COLIBACILLOSIS, BLOATING, GAS, FLATULENCE, CONSTIPATION, GASTROENTERITIS, BACTERIAL VAGINOSIS, LEUKORRHEA, APHTHOUS STOMATITIS, APHTHOUS ULCER, DENTAL CARIES, GINGIVITIS, DENTAL PLAQUE, PERIODONTAL DISEASE, DAMAGED SKIN TISSUE; bacterial preparations for medical and veterinary use for the treatment of DIARRHEA, DYSBIOSIS, LOOSE DROPPINGS, WET LITTER and AMMONIA GENERATION, MASTITIS, NECROTIC ENTERITIS, SALMONELLOSIS and COLIBACILLOSIS, BLOATING, GAS, FLATULENCE, CONSTIPATION, GASTROENTERITIS, BACTERIAL VAGINOSIS, LEUKORRHEA, APHTHOUS STOMATITIS, APHTHOUS ULCER, DENTAL CARIES, GINGIVITIS, DENTAL PLAQUE, PERIODONTAL DISEASE, DAMAGED SKIN TISSUE; dietetic food and substances adapted for medical or veterinary use; food for babies; dietary supplements for human beings and animals; medicinal, nutritional and pharmaceutical preparations and substances for the treatment of DIARRHEA, DYSBIOSIS, LOOSE DROPPINGS, WET LITTER and AMMONIA GENERATION, MASTITIS, NECROTIC ENTERITIS, SALMONELLOSIS and COLIBACILLOSIS, BLOATING, GAS, FLATULENCE, CONSTIPATION, GASTROENTERITIS, BACTERIAL VAGINOSIS, LEUKORRHEA, APHTHOUS STOMATITIS, APHTHOUS ULCER, DENTAL CARIES, GINGIVITIS, DENTAL PLAQUE, PERIODONTAL DISEASE, DAMAGED SKIN TISSUE; |
| SEIKEN | DENKA COMPANY LIMITED | 1-1, NIHONBASHI-MUROMACHI 2-CHOME, CHUO-KU TOKYO 103-8338 Japan | Cultures of microorganisms for medical diagnostic use; Biological tissue cultures for medical purposes; Reagents used for medical diagnoses and medical analysis; vaccines; gauze for dressings; empty capsules for pharmaceuticals; adhesive plasters for medical purposes; bandages for dressings;The wording SEIKEN has no meaning in a foreign language.;Sanitary masks for medical purposes; Pacifiers for babies; Dropping pipettes for medical purposes; cotton swabs for medical use; Contraceptive apparatus; Medical machines and apparatus for diagnosing infectious diseases and analyzing body fluids; urinals being vessels for medical purposes; bed pans; ear picks; |
| SHIGACTIVE | Intralytix, Inc. | Intralytix 8681 Robert Fulton Drive Columbia MD 21046 | Cultures of microorganisms for medical or veterinary use;SHIG ACTIVE; |
| TRANSBIOLOGICS | PEBBLE LABS INC. | 433 PASEO DE PERALTA SUITE 200 SANTA FE NM 87501 | Cultures of microorganisms for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Biological preparations for the treatment of infectious diseases in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target animal pathogen genes; Biological preparations for the treatment of infectious diseases in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target plant pathogen genes; Biological preparations for the treatment of viral infections in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target viral pathogen genes; Biological preparations for the treatment of bacterial infections in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target bacterial pathogen genes; Biological preparations for the treatment of fungal diseases, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target fungal pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in animals, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Probiotic preparations for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in animals, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified enteric bacteria for use in therapeutic treatment of pathogens in animals; Medical, biological and pharmaceutical preparations for the prevention and treatment of infectious diseases in plants and animals; biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals; Cultures of microorganisms for medical or veterinary use, namely, biological RNA-based therapeutic agents that inhibit the expression of target genes in plant pests and herbivores;TRAN BIOLOGICS;Cultures of microorganisms other than for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Cultures of microorganisms other than for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in plants, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Cultures of microorganisms other than for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in plants, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions use as ingredients for food and beverages, namely, genetically engineered probiotic bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions for use as ingredients for food and beverages, namely, genetically modified probiotic bacteria configured to produce bioavailable nutritional compounds; Cultures of microorganisms for medical or agricultural use, namely, genetically modified endophytic bacteria for use in therapeutic treatment of pathogens in plants; |
| TRANSBIOTICS | PEBBLE LABS INC. | 433 PASEO DE PERALTA SUITE 200 SANTA FE NM 87501 | Cultures of microorganisms for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Biological preparations for the treatment of infectious diseases in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target animal pathogen genes; Biological preparations for the treatment of infectious diseases in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target plant pathogen genes; Biological preparations for the treatment of viral infections in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target viral pathogen genes; Biological preparations for the treatment of bacterial infections in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target bacterial pathogen genes; Biological preparations for the treatment of fungal diseases, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target fungal pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in animals, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Probiotic preparations for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in animals, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified enteric bacteria for use in therapeutic treatment of pathogens in animals; Medical, biological and pharmaceutical preparations for the prevention and treatment of infectious diseases in plants and animals; biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals; Cultures of microorganisms for medical or veterinary use, namely, biological RNA-based therapeutic agents that inhibit the expression of target genes in plant pests and herbivores;Cultures of microorganisms other than for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Cultures of microorganisms other than for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in plants, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Cultures of microorganisms other than for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in plants, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions use as ingredients for food and beverages, namely, genetically engineered probiotic bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions for use as ingredients for food and beverages, namely, genetically modified probiotic bacteria configured to produce bioavailable nutritional compounds; Cultures of microorganisms for medical or agricultural use, namely, genetically modified endophytic bacteria for use in therapeutic treatment of pathogens in plants; |
| TRANSBIOTICS | Pebble Labs, Inc. | 100 ENTRADA DR LOS ALAMOS NM 87544 | Cultures of microorganisms for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Biological preparations for the treatment of infectious diseases in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target animal pathogen genes; Biological preparations for the treatment of infectious diseases in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target plant pathogen genes; Biological preparations for the treatment of viral infections in plants, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target viral pathogen genes; Biological preparations for the treatment of bacterial infections in animals, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target bacterial pathogen genes; Biological preparations for the treatment of fungal diseases, namely, biotheraputics consisting of genetically modified microorganisms that express RNA-based therapeutic agents that inhibit the expression of target fungal pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in animals, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Probiotic preparations for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in animals, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Cultures of microorganisms for medical or veterinary use, namely, genetically modified enteric bacteria for use in therapeutic treatment of pathogens in animals; Medical, biological and pharmaceutical preparations for the prevention and treatment of infectious diseases in plants and animals; biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals; Cultures of microorganisms for medical or veterinary use, namely, biological RNA-based therapeutic agents that inhibit the expression of target genes in plant pests and herbivores;Cultures of microorganisms other than for medical and veterinary use, namely, genetically modified microorganisms that express interfering molecules that inhibit the expression of target genes; Cultures of microorganisms other than for medical or veterinary use, namely, genetically modified microorganisms for use in therapeutic treatment of pathogens in plants, namely, microorganisms that express RNA-based therapeutic agents that inhibit the expression of target pathogen genes; Cultures of microorganisms other than for medical or veterinary use, namely, probiotic compositions for use in therapeutic treatment of pathogens in plants, namely, genetically engineered bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions use as ingredients for food and beverages, namely, genetically engineered probiotic bacteria that express RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Probiotic compositions for use as ingredients for food and beverages, namely, genetically modified probiotic bacteria configured to produce bioavailable nutritional compounds; Cultures of microorganisms for medical or agricultural use, namely, genetically modified endophytic bacteria for use in therapeutic treatment of pathogens in plants; |
Where the owner name is not linked, that owner no longer owns the brand |
|||
Technical Examples
- The present invention features improved methods for producing pantoate and pantothenate utilizing microorganisms having modified pantothenate biosynthetic enzyme activities. In particular, the invention features methods for reducing byproduct formation and increasing yields and purity of desired product. Recombinant microorganisms and conditions for culturing same are also are featured. Also featured are compositions produced by such microorganisms.